CAMKK2 and Alzheimer disease: CaMKK2 downstream effector AMPK was found deregulated in the brain of AD patients where it co-localized with phosphorylated tau protein in pre-tangle and neurofibrillary tangle (NFT)-bearing neurons (Vingtdeux et al., 2011).